Most important of all, we gained a new level of empathy and understanding for patients diagnosed with diabetes whose diagnosis requires that they are constantly mindful and attentive to the balance of diet, exercise, and lifestyle in their day-to-day lives.
Clinical pharmacists in the ED are well positioned to facilitate adoption of ED-initiated buprenorphine and improve the treatment of patients with OUD.
Patients who received telemedicine alone had worse glycemic control and less improvement in hemoglobin A1c levels.
Studies have shown that higher expression of CYP2D6 alleles in adults results in excessive production of active metabolites, leading to either therapeutic failure, increased exposure, or more severe adverse effects.
In the ambulatory setting, oncology pharmacists independently prescribe medications to support and manage therapy toxicities for cancer patients.
Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.
Anaïs Webster Mennuti, PharmD and Kristin Speer, PharmD, BCPS, discuss their new documentary that highlights the understaffed and overwhelmed reality of retail pharmacy.
Recognizing that culture is a multifaceted concept can lead to more careful and thoughtful use of the term.
Stress may have more of an effect on migraines than COVID-19 infection or vaccination.
Tune in to this episode of Pharmacy Focus for a deep dive into the world of independent pharmacists prescribing, featuring insights and expertise from Deeb Eid.
To develop the next generation of pharmacy leaders, pharmacists should receive effective training from the beginning of their careers.
Pharmacists' expertise is crucial in educating patients about regulatory changes, helping them navigate alternative formulations, and providing insights into evidence-based choices.
Pharmacists in community and retail practices are stepping out from behind the counter and becoming more involved in patient care.
The report allows management to provide guaranteed assessments throughout the screenings that could aid early detection, diagnosis, and lung cancer treatment.
If vaccination coverage was increased by 100%, outpatient care could be reduced by 81.2%, hospitalizations by 91.7%, and deaths by 91.3%.
Malignant hyperthermia can result in a rare anesthetic emergency and can be fatal.
Those who were exposed to the clinically acquired stomach bacteria had a 24% increased risk of Alzheimer disease after a decade of onset.
Nearly 75% of patients who had an initial complete response with mosunetuzumab maintained that complete response after 3 years.
Conclusions could not be made regarding whether lower risk was associated with improvement in heart failure or if the success of optimal medications led to better clinical outcomes.
In-hospital mortality and the Medicare Bundled Payments for Care Improvement (BPCI) model are not associated with changes in odds for Black individuals or female individuals.
Investigators optimized the assay during development and qualification to be used in the clinical setting for pneumococcal conjugate vaccines.
Although machine learning models demonstrate potential to improve early detection of Alzheimer disease, sample sizes that underrepresent ethnic and racial groups result in unfairness.
Findings may translate to a safe intervention for older women at risk of osteoporosis.
The prospective observational study assessed a 2-year increasing lung cancer diagnosis risk, lung cancer characteristics, and the overall survival between LNP and LDCT screening.
Eliminating certain factors within the GRN resulted in the network shutting down, potentially leading to cancer cell death due to an inability to replicate, according to the study authors.
New CAR T development method infuses immune T cells from healthy people into patients to improve outcomes.
Genetic risk, pertaining to sodium and potassium pathways, could help tailor interventions specifically to patients for the management of hypertension.
Adalimumab-aqvh (Yusimry; Coherus Biosciences) entered the market in July 2023, following approval by the FDA in December 2021.
The risk of poor cognitive performance was nearly double in participants who had the greatest number of sleep disturbances compared to the least.
This study showed the importance of a multidisciplinary team’s expertise to investigate a clinical inquiry beyond the scope of the clinicians’ skillset and their access to necessary technology.
